Inhibitors of epidermal growth factor receptor tyrosine kinase: Novel C-5 substituted anilinoquinazolines designed to target the ribose pocket-Reference-Cited by-同舟云学术

Inhibitors of epidermal growth factor receptor tyrosine kinase: Novel C-5 substituted anilinoquinazolines designed to target the ribose pocket

Published:2006-03 Issue:6 Volume:16 Page:1633-1637
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Ballard Peter,Bradbury Robert H.,Harris Craig S.,Hennequin Laurent F.A.,Hickinson Mark,Johnson Paul D.,Kettle Jason G.,Klinowska Teresa,Leach Andrew G.,Morgentin Remy,Pass Martin,Ogilvie Donald J.,Olivier Annie,Warin Nicolas,Williams Emma J.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference19 articles.

1. Untangling the ErbB signalling network

2. Epidermal growth factor-related peptides and their receptors in human malignancies

3. Gefitinib — a novel targeted approach to treating cancer

4. Erlotinib: a new therapeutic approach for non-small cell lung cancer

5. Small molecule tyrosine kinase inhibitors: clinical development of anticancer agents

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ligand and structure based hierarchical virtual screening cascade for finding novel epidermal growth factor receptor inhibitors;Chemical Biology & Drug Design;2023-10-17

2. Computer aided drug discovery (CADD) of a thieno[2,3-d]pyrimidine derivative as a new EGFR inhibitor targeting the ribose pocket;Journal of Biomolecular Structure and Dynamics;2023-05-02

3. Synthesis of selective PAK4 inhibitors for lung metastasis of lung cancer and melanoma cells;Acta Pharmaceutica Sinica B;2022-06

4. Bestowal of Quinazoline Scaffold in Anticancer Drug Discovery;Anti-Cancer Agents in Medicinal Chemistry;2021-06-16

5. Three-Dimensional Interactions Analysis of the Anticancer Target c-Src Kinase with Its Inhibitors;Cancers;2020-08-18